Compugen
Most recent annual filing: 2026-03-02
- Rilvegostomig HER2 readout2026Rilvegostomig HER2 readout, 2026, notable
- Rilvegostomig ARTEMIDE-01 readout2H 2026Rilvegostomig ARTEMIDE-01 readout, 2H 2026, notable
- GS-0321 Ph1 interimLate 2026 / 2027GS-0321 Ph1 interim, Late 2026 / 2027, notable
- COM701 interim1Q 2027COM701 interim, 1Q 2027, major
Bar width shows how precise the guidance is — a pin is a stated date, a wide band a six-month window. Deeper blue means more of the thesis rides on the event; it is not a view on the stock.
Pipeline (7 active programs)
Technology platforms
Unigen
AI/ML powered computational drug target discovery platform using multi-omics datasets, genomics, single-cell RNA sequencing, proteomics and spatial transcriptomics to identify novel immuno-oncology drug targets for cancer immunotherapy
Biotech Distilled coverage (1)
Articles open on Substack. Some deep dives are subscriber-only.